Effect of Γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors

Journal of Virology - United States
doi 10.1128/jvi.00017-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Anti-Tumor Effect of Oncolytic Herpes Simplex Virus G47delta on Human Nasopharyngeal Carcinoma

Chinese Journal of Cancer
2011English

The Role of Herpes Simplex Virus Type 1 Γ34.5 in the Regulation of IRF3 Signaling.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2017English

Oncolytic Herpes Simplex Virus ICP47 Deletion Reverses Tumor Immune Evasion

Yangtze Medicine
2018English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

2005English

Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus in P53- Breast Cancer Cells

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate Cancer

2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy